Iambic
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5627 Oberlin Dr Ste 120, San Diego, Cali...Phone Number
(619) 330-5499Website
www.iambic.aiRevenue
$29.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
4
1
1
About Iambic
Iambic is a clinical-stage life-sciences and technology company developing novel medicines using its AI-driven discovery and development platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated delivery of new drug candidates to human clinical trials with unprecedented speed and across multiple target classes and mechanisms of action. Iambic is advancing a pipeline of potential best-in-class and first-in-class clinical assets, both internally and in partnership, to address urgent unmet patient needs.Explore more
Iambic Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Iambic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Iambic has new funding data
Click to see if Iambic had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Iambic recently announced quarterly report
Iambic, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Iambic is spiking on competitors!
Check if Iambic has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Iambic launches new products
Congratulate Masked Content for being promoted to Masked Content at Iambic
Recommended Actions
Find VP level buyers at Iambic
Find more new buyers
Compare Similar Companies to Iambic
Compare insights from companies similar to Iambic, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Iambic
$29.6M
51-200
Private
$277.8M
2020
Michael SecoraChief Financial Officer & Chief Corporate Development Officer
Company Profile Activity
Activity Insights
Iambic is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Iambic is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Iambic.
Iambic financials insights
Gather financial insights about Iambic, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series B
$150M
2025
Other Financing Round
$100M
2026
Private Equity
$27.8M
Iambic Tech Stack
A closer look at the technologies used by Iambic
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Iambic News & Media
AI Drug Discovery Startup Iambic Raises $100M Following Encouraging Cancer Drug Data
Iambic, a clinical-stage life science and technology company that uses artificial intelligence to develop medicines has raised more than $100 million in an oversubscribed financing round. The Nov. 10 announcement followed Iambic's presentation of clinical data that showed its drug IAM1363, "demonstrated anti-tumor activity and a favorable safety profile" for cancers caused by higher-than-normal levels of the HER2 protein. The results were presented in October at the European Society for MedicalRevolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates
REDWOOD CITY, Calif. and SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, and Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced a technology and research collaboration to pursue novel drug candidates using Iambic’s leading AI modIambic Taps Lambda for Increased AI Compute as it Develops the Next Generation of Enchant, a Breakthrough AI Molecular Property Prediction Model for Drug Discovery
SAN JOSE, Calif.--(BUSINESS WIRE)--Lambda, the GPU cloud company founded by AI engineers, today announced that Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, has selected Lambda to provide an NVIDIA HGX B200 cluster to support the training of Enchant, its industry-leading model for molecular property prediction. Iambic’s Enchant is a breakthrough multi-modal transformer model for predicIambic Completes Dose Escalation in Ongoing Phase 1/1B Study of Lead Program IAM1363, a Small Molecule Inhibitor of Wild-Type and Oncogenic HER2 Mutant Proteins
SAN DIEGO--(BUSINESS WIRE)--Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, announced today that it has completed dose escalation in IAM1363-01, its Phase 1/1b clinical trial evaluating IAM1363, a selective and brain-penetrant small molecule inhibitor of wild-type and oncogenic mutant HER2. With completion of dose escalation, Iambic is advancing two well-tolerated doses into the dose opt
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Iambic
Sign Up For FreeTo access detailed company insights
Iambic is a clinical-stage life-sciences and technology company developing novel medicines using its AI-driven discovery and development platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated delivery of new drug c... Read More
